Stock & Company Details
Celldex Therapeutics Inc. $CLDX
Price:
N/A
N/A
79M
$2.2B
52 Week High:
N/A
10 Day Average Volume:
N/A
-6.41
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CLDX technical indicators
Latest Celldex Therapeutics Inc. (CLDX) indicator readings as of 2026-11-19.
CLDX's 14-day RSI is 40.9, in neutral territory. ADX reads 20.0, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -0.78, below the zero line.
Overview
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly effect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
Finance Bot
Ask your questions
Start by typing a question below.